Peptide-based materials for cancer immunotherapy
Lu Zhang1, Yanyu Huang1, Aaron Raymond Lindstrom1
1Department of Biochemistry and Molecular Medicine, UC Davis NCI-designated Comprehensive Cancer Center, University of California Davis, Sacramento, California 95817, United States.
Abstract:
Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional domains of proteins with highly specific immuno-regulatory functions or tumor cells fate controls. However, a systemic understanding of the interactions between the different peptides and immune systems remains unknown. This review describes the role of peptides in regulating the functions of the innate and adaptive immune systems and provides a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines. By elucidating the impacts of peptide length and formulations on their immunogenicity, peptide-based immunomodulating agents can be better utilized and dramatic breakthroughs may also be realized. Moreover, some critical challenges for translating peptides into large-scale synthesis, safe delivery, and efficient cancer immunotherapy are posed to improve the next-generation peptide-based immunotherapy.
Insights
Peptide-based immunotherapies show promise for cancer treatment by regulating immune responses. This review explores peptide cancer vaccine design, applications, and challenges for improved cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Biomaterials Science
Background:
- Peptide-based materials are promising for cancer immunotherapy.
- Current research focuses on peptide vaccines and delivery systems mimicking protein functions.
- A comprehensive understanding of peptide-immune system interactions is lacking.
Purpose of the Study:
- To review the role of peptides in regulating innate and adaptive immune systems.
- To provide a comprehensive focus on the design, categories, and applications of peptide-based cancer vaccines.
- To elucidate the impact of peptide characteristics on immunogenicity for better utilization.
Main Methods:
- Literature review of peptide-based cancer immunotherapy.
- Analysis of peptide design, formulation, and immunomodulatory functions.
- Discussion of challenges in large-scale synthesis, delivery, and clinical translation.
Main Results:
- Peptides play a crucial role in modulating both innate and adaptive immunity.
- Peptide length and formulation significantly impact immunogenicity.
- Understanding these factors is key to optimizing peptide-based immunomodulating agents.
Conclusions:
- Peptide-based cancer vaccines offer a promising avenue for cancer immunotherapy.
- Further research is needed to address challenges in synthesis, delivery, and clinical application.
- Optimizing peptide design and formulation can lead to significant breakthroughs in cancer treatment.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...


